Restricted accessResearch articleFirst published online 2020-9
Differential modulation of the contextual conditioned emotional response by CB1 and TRPV1 receptors in the ventromedial prefrontal cortex: Possible involvement of NMDA/nitric oxide-related mechanisms
Blockade of cannabinoid CB1 or vanilloid TRPV1 receptors in the ventromedial prefrontal cortex of rats respectively increases or decreases the conditioned emotional response during re-exposure to a context previously paired with footshocks. Although these mechanisms are unknown, they may involve local modulation of glutamatergic and nitrergic signaling.
Aim:
We investigated whether these mechanisms are involved in the reported effects of CB1 and TRPV1 modulation in the ventromedial prefrontal cortex.
Methods:
Freezing behavior and autonomic parameters were recorded during the conditioned response expression.
Results:
The CB1 receptors antagonist NIDA, or the TRPV1 agonist capsaicin (CPS) in the ventromedial prefrontal cortex increased the conditioned emotional response expression, and these effects were prevented by TRPV1 and CB1 antagonism, respectively. The increased conditioned emotional response evoked by NIDA and CPS were prevented by an NMDA antagonist or a neuronal nitric oxide synthase inhibitor. A nitric oxide scavenger or a soluble guanylate cyclase inhibitor prevented only the NIDA effects and the CPS effect was prevented by a non-selective antioxidant drug, as nitric oxide can also induce reactive oxygen species production.
Conclusion:
Our results suggest that CB1 and TRPV1 receptors in the ventromedial prefrontal cortex differently modulate the expression of conditioned emotional response through glutamatergic and nitrergic mechanisms, although different pathways may be involved.
AguiarDCMoreiraFATerzianAL, et al. (2014) Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) channels. Neurosci Biobehav Rev46Pt 3: 418–428.
2.
AppendinoGHarrisonSDe PetrocellisL, et al. (2003) Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists. Br J Pharmacol139: 1417–1424.
3.
AraqueACastilloPEManzoniOJ, et al. (2017) Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology124: 13–24.
4.
AuclairNOtaniSSoubrieP, et al. (2000) Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol83: 3287–3293.
5.
BeckCHFibigerHC (1995) Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: With and without diazepam pretreatment. J Neurosci15: 709–720.
6.
BradleySASteinertJR (2016) Nitric oxide-mediated posttranslational modifications: Impacts at the synapse. Oxid Med Cell Longev2016: 5681036.
7.
BredtDSSnyderSH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA86: 9030–9033.
8.
CarlénM (2017) What constitutes the prefrontal cortex?Science358: 478–482.
9.
CarriveP (2000) Conditioned fear to environmental context: Cardiovascular and behavioral components in the rat. Brain Res858: 440–445.
10.
CasarottoPCTerzianALBAguiarDC, et al. (2012) Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats. Neuropsychopharmacology37: 478–486.
11.
CavanaughDJCheslerATJacksonAC, et al. (2011) Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci31: 5067–5077.
12.
ChildersSRDeadwylerSA (1996) Role of cyclic AMP in the actions of cannabinoid receptors. Biochem Pharmacol52: 819–827.
13.
ChoiYBTennetiLLeDA, et al. (2000) Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci3: 15–21.
14.
ClausenANFranciscoAJThelenJ, et al. (2017) PTSD and cognitive symptoms relate to inhibition-related prefrontal activation and functional connectivity. Depress Anxiety34: 427–436.
15.
CrestaniCC (2016) Emotional stress and cardiovascular complications in animal models: A review of the influence of stress type. Front Physiol7: 251.
16.
CristinoLde PetrocellisLPryceG, et al. (2006) Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience139: 1405–1415.
17.
DampneyRAL (2015) Central mechanisms regulating coordinated cardiovascular and respiratory function during stress and arousal. Am J Physiol Regul Integr Comp Physiol309: R429–R443.
18.
De NovellisVVitaDGattaL, et al. (2011) The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats. Mol Pain7: 7.
19.
DielenbergRACarrivePMcGregorIS (2001) The cardiovascular and behavioral response to cat odor in rats: Unconditioned and conditioned effects. Brain Res897: 228–237.
20.
EgertováMGiangDKCravattBF, et al. (1998) A new perspective on cannabinoid signalling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc Biol Sci265: 2081–2085.
21.
FassiniAScopinhoAAResstelLBM, et al. (2014) Opioid receptors in the prelimbic cortex modulate restraint stress-induced cardiovascular responses in the rat. Neuropharmacology85: 367–374.
22.
FendtMFanselowMS (1999) The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev23: 743–760.
23.
FrysztakRJNeafseyEJ (1991) The effect of medial frontal cortex lesions on respiration, ‘freezing,’ and ultrasonic vocalizations during conditioned emotional responses in rats. Cereb Cortex1: 418–425.
24.
FrysztakRJNeafseyEJ (1994) The effect of medial frontal cortex lesions on cardiovascular conditioned emotional responses in the rat. Brain Res643: 181–193.
GoldsteinDS (1987) Stress-induced activation of the sympathetic nervous system. Baillieres Clin Endocrinol Metab1: 253–278.
27.
HerdJA (1991) Cardiovascular response to stress. Physiol Rev71: 305–330.
28.
KatonaIFreundTF (2012) Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci35: 529–558.
29.
KawaharaHDrewGMChristieMJ, et al. (2011) Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. Br J Pharmacol163: 1214–1222.
30.
KozlowskaKWalkerPMcLeanL, et al. (2015) Fear and the defense cascade: Clinical implications and management. Harv Rev Psychiatry23: 263–287.
31.
KumarSSitasawadSL (2009) N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells. Life Sci84: 328–336.
32.
LafourcadeMElezgaraiIMatoS, et al. (2007) Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One2: e709.
33.
LiD-PChenS-RFinneganTF, et al. (2004) Signalling pathway of nitric oxide in synaptic GABA release in the rat paraventricular nucleus. J Physiol554: 100–110.
34.
LipinaCHundalHS (2017) The endocannabinoid system: ‘NO’ longer anonymous in the control of nitrergic signalling?J Mol Cell Biol9: 91–103.
35.
LisboaSFGuimarãesFS (2012) Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray. Neuropharmacology62: 2455–2462.
36.
LisboaSFMagestoACAguiarJC, et al. (2013) Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats. Neuropharmacology75: 86–94.
37.
LisboaSFReisDGda SilvaAL, et al. (2010) Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Int J Neuropsychopharmacol13: 1163–1173.
38.
MarsicanoGLutzB (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci11: 4213–4225.
39.
MezeyETóthZECortrightDN, et al. (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA97: 3655–3660.
40.
MiladMRRauchSLPitmanRK, et al. (2006) Fear extinction in rats: Implications for human brain imaging and anxiety disorders. Biol Psychol73: 61–71.
41.
MoghaddamB (1993) Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: Comparison to hippocampus and basal ganglia. J Neurochem60: 1650–1657.
42.
MoreiraFAAguiarDCGuimarãesFS (2007) Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology52: 958–965.
43.
MoreiraFAAguiarDCTerzianALB, et al. (2012) Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?Neuroscience204: 186–192.
44.
MoriyoshiKMasuMIshiiT, et al. (1991) Molecular cloning and characterization of the rat NMDA receptor. Nature354: 31–37.
45.
NicolBRowbothamDJLambertDG (1996) mu- and kappa-opioids inhibit K+ evoked glutamate release from rat cerebrocortical slices. Neurosci Lett218: 79–82.
46.
ParkJMoghaddamB (2017) Impact of anxiety on prefrontal cortex encoding of cognitive flexibility. Neuroscience345: 193–202.
47.
PatelSHillMNCheerJF, et al. (2017) The endocannabinoid system as a target for novel anxiolytic drugs. Neurosci Biobehav Rev76: 56–66.
48.
PaxinosGWatsonC (2007) The Rat Brain in Stereotaxic Coordinates. 6th ed. San Diego: Academic Press.
49.
QuijanoCAlvarezBGattiRM, et al. (1997) Pathways of peroxynitrite oxidation of thiol groups. Biochem J322: 167–173.
50.
QuirkGJBeerJS (2006) Prefrontal involvement in the regulation of emotion: Convergence of rat and human studies. Curr Opin Neurobiol16: 723–727.
51.
RadleyJJAriasCMSawchenkoPE (2006) Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. J Neurosci26: 12967–12976.
52.
ResstelLBMCorrêaFMA (2005) Pressor and tachycardic responses evoked by microinjections of L-glutamate into the medial prefrontal cortex of unanaesthetized rats. Eur J Neurosci21: 2513–2520.
53.
ResstelLBMCorrêaFMA (2006) Injection of l-glutamate into medial prefrontal cortex induces cardiovascular responses through NMDA receptor - nitric oxide in rat. Neuropharmacology51: 160–167.
54.
ResstelLBMCorrêaFM de AGuimarãesFS (2008) The expression of contextual fear conditioning involves activation of an NMDA receptor-nitric oxide pathway in the medial prefrontal cortex. Cereb Cortex18: 2027–2035.
55.
ResstelLBMJocaSRLGuimarãesFG, et al. (2006a) Involvement of medial prefrontal cortex neurons in behavioral and cardiovascular responses to contextual fear conditioning. Neuroscience143: 377–385.
56.
ResstelLBMJocaSRLMoreiraFA, et al. (2006b) Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav Brain Res172: 294–298.
57.
SchmidtHHGagneGDNakaneM, et al. (1992) Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem40: 1439–1456.
58.
SeelyKABrentsLKFranksLN, et al. (2012) AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies. Neuropharmacology63: 905–915.
59.
SelvakumarBHuganirRLSnyderSH (2009) S-nitrosylation of stargazin regulates surface expression of AMPA-glutamate neurotransmitter receptors. Proc Natl Acad Sci USA106: 16440–16445.
60.
SmartDJermanJC (2000) Anandamide: An endogenous activator of the vanilloid receptor. Trends Pharmacol Sci21: 134.
61.
SpiacciGBLAnteroLSReisDG, et al. (2016) Dorsal hippocampus cannabinoid type 1 receptors modulate the expression of contextual fear conditioning in rats: Involvement of local glutamatergic/nitrergic and GABAergic neurotransmissions. Eur Neuropsychopharmacol26: 1579–1589.
62.
StarowiczKMaioneSCristinoL, et al. (2007) Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J Neurosci27: 13739–13749.
63.
SteketeeJD (2003) Neurotransmitter systems of the medial prefrontal cortex: Potential role in sensitization to psychostimulants. Brain Res Brain Res Rev41: 203–228.
64.
TerzianALBAguiarDCGuimarãesFS, et al. (2009) Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray. Eur Neuropsychopharmacol19: 188–195.
65.
TerzianALBdos ReisDGGuimarãesFS, et al. (2014) Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats. Psychopharmacology231: 149–157.
66.
TsouKBrownSSañudo-PeñaMC, et al. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience83: 393–411.
67.
UlianaDLHottSCLisboaSF, et al. (2016) Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning. Neuropharmacology103: 257–269.
68.
WangSPatonJFRKasparovS (2007) Differential sensitivity of excitatory and inhibitory synaptic transmission to modulation by nitric oxide in rat nucleus tractus solitarii. Exp Physiol92: 371–382.
69.
WilsonRINicollRA (2002) Endocannabinoid signaling in the brain. Science296: 678–682.
70.
WorleyNBHillMNChristiansonJP (2017) Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis. Prog Neuropsychopharmacol Biol Psychiatry85: 180–188.
ZygmuntPMPeterssonJAnderssonDA, et al. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature400: 452–457.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
